Inspira Technologies launches programme examining artificial womb
The company plans to examine how its INSPIRA ART100 device could be used in place of traditional mechanical ventilators in hospitals.
04 April 2024
04 April 2024
The company plans to examine how its INSPIRA ART100 device could be used in place of traditional mechanical ventilators in hospitals.
The pulsed field ablation market in cardiovascular treatment is growing quickly.
The development can enhance the management of bacteremia by delivering AST results with unprecedented speed.
The Vscan Air SL with Caption AI is designed to simplify the process of capturing cardiac images.
The MRI will provide ultra-detailed information for diagnosing neurodegenerative diseases such as Alzheimer's and Parkinson's.
It is said to be the first-ever FDA approval for an AI software as a medical device for diagnosis and prediction of sepsis.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.